. Deep and wide thigh wound after excision of zygomycotic lesion.
Conclusions:
Aggressive surgical wound care with resolution of cutaneous zygomycosis enabled subsequent transplantation in this young infant with a favorable outcome.
High Serum B Cell Activating Factor Levels Inversely Correlate with low B Cells in both Common Variable Immune Deficiency and Good's Syndrome
Georgia Vriniotis, Lulu Sun, Christos Tsoukas.
Division of Clinical Immunology McGill University Health Center Montreal, Quebec, Canada
Background: Causes for Common Variable Immune Deficiency (CVID) include: failure of B cell activation and maturation, altered somatic hypermutation and defective cell membrane signalling. CVID is associated with a reduction in class switched memory B cells. Similar impairments in B cell development have been thought to occur in Good' s Syndrome (GS). This disorder is characterized by thymoma, hypogammaglubulinemia, as well as a clinical phenotype of severe B and T cell immune deficiency. Early and systematic long term data are not available for most cases with GS and few cohorts have been studied systematically. B Cell Activating Factor (BAFF) and its receptor (BAFF-R) are necessary for B cell growth. BAFF is synthesized by cells of myeloid origin as a transmembrane protein and later cleaved to produce soluble BAFF. Stimulation of B cells with BAFF significantly retards their death and leads to B cell maturation. Low B cells are a poor prognostic indicator in CVID patients. The role of BAFF as it relates to B cells in GS is unknown. Objectives: We aimed to study the relationship of BAFF and BAFF-R to B cell memory phenotypes in CVID and GS. Methods: We quantified BAFF and BAFF-R levels of 44 adults with CVID, 4 with GS and 25 healthy adult controls and compared the amount of BAFF and BAFF-R to the number of switched (CD27+IgD-) and unswitched (CD27-IgD+) B cells using anti-CD27, anti-CD19, anti-IgD, and anti-BAFF-R-FITC. Serum BAFF levels were measured using an enzyme-linked immunoassay. Results: An absence of B cells occurred in all GS patients and significant decrease of class switched IgD-CD27+ B cells in CVID patients was noted when compared to controls (p<0.0001). There was no significant difference of unswitched IgD+CD27-levels between CVID patients to healthy donors (p<0.300). A significant difference between the serum BAFF of CVID and GS patients (p<0.01) as well as GS to controls (p<0.0002) was observed. Mean values were 12,678 pg/ml for GS and 3,070 and 968 pg/ml respectively for CVID and controls. Serum BAFF levels in CVID patients correlated with lower %B cells (p<0.0051) but no correlation was noted between BAFF levels of CVID patients to either IgD+CD27-(p<0.71) or IgD-CD27+ (p<0.58) B cells. Conclusions: BAFF overexpression correlates with a lack of B cells in both CVID and GS. The significance of this association with respect to B cell development remains to be determined. 
STAT3 Mutations in Job's Syndrome

The First Report of Somatic Mutation Reversion X-Linked Chronic Granulomatous Disease
Gulbu Uzel, Douglas Kuhns, Gilda Linton, Paul Quie, Steven Holland.
NIH, NIAID, Laboratory of Clinical Infectious Diseases, Bethesda, MD, USA
Introduction: X-linked chronic granulomatous disease (CGD) is caused by mutations in the CYBB gene, which impair gp91phox function and therefore lead to deficient superoxide generation by the phagocyte NADPH oxidase system. This leads to defective killing of certain bacteria and fungi and results in severe infections and granuloma formation. Case: A 20-year-old man with X-linked CGD had a long history of classic CGD and severe inflammatory bowel disease requiring colonic diversion. He had two distinct populations of neutrophils by neutrophil oxidative burst testing of peripheral blood. In two independent measurements of neutrophil oxidative burst by dihydrorhodamine (DHR) assay, 97% of peripheral blood neutrophils failed to oxidize dihydrorhodamine (DHR-), while 3% had a normal oxidative capacity (DHR+). Sorted DHR+ and DHR-cells were studied by microsatellite analyses, which proved patient origin of both the DHR+ and DHR-cells. The DHR-cells and buccal mucosal epithelial cells and unsorted peripheral blood mononuclear cells had the mutation 676C>T, which causes a premature stop (R226X) in CYBB. In contrast, the DHR+ cells had the wild-type sequence, 676C leading to a normal protein. Therefore, since he had the majority of his peripheral blood and his buccal cells mutant, and only a small percentage reverted to normal, we believe that he has reverted the mutation in a small population of his neutrophil precursors. Exploration of other cell lines (lymphoid, monocyte, etc) is underway. Discussion: Somatic mosaicism due to site-specific reversions of inherited mutations to wild type has been described in other immunodeficiencies and has been linked to milder disease in some cases. This is the first report of a reversion mutation in X-linked CGD, and the only report of a reversion mutation affecting neutrophils in a primary phagocyte defect. Reversion mutations can occur in neutrophils, just as they do in lymphocytes and may be more common than previously thought.
Filamentous Fungal Pneumonias in Hyper IgE Syndrome
Donald Vinh, Alexandra F. Freeman, Amy Hsu, Steven Holland.
National Institute of Allergy & Infectious Diseases Laboratory of Clinical Infectious Diseases, Bethesda, USA
Background: Autosomal dominant hyper-IgE syndrome (AD-HIES, Job' s syndrome) is a primary immunodeficiency characterized by recurrent staphylococcal abscesses, pneumonia, eczema, and elevated serum IgE. Connective tissue defects are also frequent. AD-HIES results from heterozygous hypomorphic mutations in the STAT3 gene, primarily affecting either the SH2 or DNA-binding domains. Filamentous fungal pneumonias (FFP), particularly with Aspergillus spp., have been reported in patients with clinically suspected AD-HIES. However, these reports pre-dated the ability to genotypically confirm the patients' diagnoses and have been limited in sample size, precluding comprehensive understanding of this infection in AD-HIES. We sought to determine the prevalence of FFP in a large cohort of patients with confirmed AD-HIES. Methods: Retrospective chart review of all AD-HIES patients followed at the NIH, for which the diagnosis was confirmed by genetic sequencing. Results: 56 AD-HIES patients with STAT3 mutations were identified: 22 (39.3%) had no radiological evidence of lung cysts (includes cavities, pneumatoceles), while 34 (60.7%) did. Among those without cysts, none (0%) developed FFP. Among those with lung cysts, 13 (38.2%) developed FFP. Aspergillus/Neosartorya spp. were most common (11 total, 84.6%); infection with S. apiospermum (n=1) and H. capsulatum (n=1) also occurred. Multiple episodes of FFP frequently occurred in affected patients and did not occur exclusively in pre-existing cysts. Patients were stratified based on their mutation (SH2, n=28; DNA, n=28). Lung cysts were equally frequent in each group (n=17 for both). The number of patients in each group with lung cysts developing FFP was similar (SH2: 7/17 (41.2%); DNA: 6/17 (35.3%)) as was the median age at onset of 1st FFP (SH2: 30.5 yrs; DNA: 35.5 yrs). Treatment modalities varied and included antifungal agents (systemic, occasionally adjunctive intra-cavitary) with or without surgical resection. Mortality occurred more frequently in the DNA group (3/6; 50%) than in the SH2 group (0/7; 0%). Conclusions: Patients with AD-HIES with lung cysts are at significantly increased risk for FFP, typically in their third decade of life. FFP do not necessarily occur only in pre-existing cysts/cavities, suggesting that cysts/cavities may be a marker for susceptibility rather than a cause of the infection. Aspergillus spp. are the primary pathogens. The mortality rate is significant and possibly related to genotype. Background: Two Qatari sisters (5 and 12 yrs.) with a family history of consanguinity (parents are first cousins) and suspected neutrophil dysfunction had frequent severe skin and mucosal ulcera-
